Company intelligence / Profile preview

Intelliseq

Krakow, Lesser Poland Voivodeship, Polandintelliseq.com ↗

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

Intelliseq’s iFlow platform enables automated, modular workflows for next-generation sequencing (NGS) data analysis, supporting rapid diagnosis of hereditary disorders, cancer profiling, and research into complex conditions like chronic fatigue syndrome. The company partners with major institutions to deliver scalable clinical genomics solutions globally.

Therapeutic areas: ImmunologyOncologyRare DiseasesInfectious Diseases
Modalities: Not applicable (Intelliseq provides bioinformatics platforms and services, not therapeutics)
Industry: Molecular Diagnostics

Partnerships

DNAnexus (integration of variant interpretation/reporting in precision health cloud)Metrodora Institute/PrecisionLife (tools for chronic fatigue syndrome/long COVID risk assessment)

Beyond the preview

Go deeper on Intelliseq.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intelliseq.

Explore the full profile